|Truvada & Isentress
Apr 17, 2011
| Response from Dr. Young
Hello and thanks for your post.
Unfortunately, once-daily raltegravir (ISENTRESS) was found in the QDMRK study to not be as effective as twice-daily-- for this reason, the Truvada+Isentress regimen won't be once-daily.
There are other once-daily integrase inhibitors (namely elvitegravir and dolutegravir) that are in development. If these programs successfully conclude with regulatory agency approval, then we could see an entirely once-daily integrase-containing regimen.
Hope this helps, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.